<img alt="" height="1" width="1" />Lexicon 1Q net loss widens on lower revenueBusinessWeekLexicon has several drugs in development, aimed at diabetes, irritable bowel syndrome, and rheumatoid arthritis. The company reported said a net loss of ...<nobr>and more »</nobr> |